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The Effect Of 
AUREOMYCIN 
Upon the Growth of Dairy Calves 
When Administered Orally. Subcutaneously 
And lntramuscularly1 
By MAGNAR RONNING, C. W. RICHARDSON,' 
E. R. BEROUSEK and C. L. NORTON 
Department ol Dairying 
It has been shown that the growth rate of dairy calves is increased 
by the oral administration of small amounts of aureomycin (1, 2, 3, 5, 
6, 7, 8, 9, 10, 11, 13 14, 15, 18).• Previous work at this Station (9) indi-
cated that 70 mg. of aureomycin per day in a single oral dose was ef-
fective in stimulating the growth rate of calves as measured by body-
weight during the first five weeks of life. 
While it has been shown that oral administration of this anti-
biotic stimulates growth, there is a question as to whether or not 
aureomycin might stimulate growth when given parenterally. Re-
sults of contemporary investigations by Rusoff and associates (16) 
show that weekly intramuscular injections of 400 mg. of aureomycin were 
effective in increasing the bodyweight gains of young dairy calves. Re-
sults of work by Noland, et al. (12) indicate that the subcutaneous 
implantation of bacitracin pellets produced increased bodyweight gains 
in young pigs. Terrill, et al. (17), however, concluded that the wean-
ing weights of pigs or the survival of pigs to weaning age were not in-
creased by the subcutaneous implantation of either bacitracin, penicillin 
or aureomycin pellets. 
The purpose of this trial was to study the effects of different levels 
of aureomycin upon the growth rate of dairy calves when given orally, 
subcutaneously and intramuscularly. 
1 Work supported in part by Lederle Laboratories Division, American Cyanamid Company, 
Pearl River, New York. 
• Present address: Eastern Oklahoma A. & M. College, Wilburton, Okla. 
• Numbers in parentheses refer to Literature Cited, page I 0. 
[3] 
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Experimental Procedure 
Sixty male and female calves of three breeds (Guernsey, Aryshire 
and Holstein) were used in two experiments. All calves were removed 
from their dams 48 hours after birth and placed in individual tie-stalls 
for the duration of the 4-weeks trial. 
The temperature of the barn in which the calves were housed was 
thermostatically controlled at approximately 65• F. during the fall 
and winter when Experiment I was in progress. Experiment II was 
conducted during the spring and summer, and the temperature of the 
barn during this period ranged from so• to 85• F. 
The calves were allotted to experimental groups in which the 
initial bodyweight and number of calves of each breed were kept as 
nearly constant as possible. All calves were fed a ration which con-
sisted of one pound of Holstein herd milk per 12.5 lbs. bodyweight 
daily, good quality prairie hay, and a 16 percent protein calf starter 
offered ad lib. 
In the first of the two experiments, five groups of seven calves 
each were treated as follows: 
Group A calves served as untreated controls. 
Calves in Group B were given a capsule containing 250 mg. crystal-
line aureomycin hydrochloride once weekly per os. 
Calves in Group C received a weekly subcutaneous implantation 
of 60 mg. aureomycin hydrochloride pellets at the base of the ear by 
the use of a stilbestrol implant gun. This appeared to be the most 
reasonable dosage for a single implantation for the purpose of this 
study. Sixty mg. aureomycin administered weekly by implant as com-
pared to 250 mg. given orally is a I to 4 ratio of parenteral to oral 
administration. Results of studies by Dowling, et al. (4) with humans 
indicated that this dosage ratio should result in comparable blood levels. 
Calves in Group D were given a capsule of 70 mg. of crystalline 
aureomycin hydrochloride per os daily and were used as a reference 
group in order to have a comparison between the present study and 
previous work. 
In Group E, the calves were injected intramuscularly with 60 mg. 
aureomycin (aureomycin-AlGI complex dispersed in sesame oil) weekly 
for comparison with the implanted group. 
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After studies had been completed with 35 calves, a second experi-
ment of similar design was conducted to study the effect of other levels 
of administration. This experiment involved five groups of five calves 
each. Groups A and D were continued as in Experiment I to serve 
as a control and a reference group, respectively. Group F was added 
to study the effect of a higher level of aureomycin (500 mg.) in a single 
weekly oral dose. In order to determine whether or not calves would 
respond to even lower amounts of aureomycin, Group H was included 
in which calves received 125 mg. weekly in a single oral dose. Group 
G was added to study a higher level of intramuscular injection. The 
calves in this group were injected once weekly with 250 mg. of aureo-
mycin. 
The effects of the treatments in both 4-weeks experiments were 
measured by weekly gains in bodyweight, changes in the height at 
withers and in chest circumference, and records of feed consumption. 
The total gain in weight from the initial day of the trial until the termi-
nation of the 4-weeks observation was the main criterion for measuring 
the effect of the treatments. Daily health observations were made on 
all the calves. 
Results and Discussion 
BODYWEIGHT GAINS 
Experiment I 
The effects of oral and parenteral administration of aureomycin 
upon the growth and feed consumption of the calves in Experiment I 
are summarized in Table I. The results indicate that 70 mg. of aureo-
mycin administered daily was effective in increasing the bodyweight 
gain over that of controls from birth to four weeks of age. These find-
ings are in agreement with previous studies at this Station. The calves 
receiving 70 mg. of aureomycin daily gained 32 percent more in body-
weight than the control calves during the 4-weeks period. 
The oral administration of 250 mg. of aureomycin in a single 
weekly dose resulted in an average bodyweight gain during the 
4-weeks period of 0.9 lb. more per calf than observed with the 
animals in the group receiving 70 mg. 
The calves in Group C, which received 60 mg. of aureomycin weekly 
by implant, and the calves in Group E, which received the same amount 
by intramuscular injection, completed the experiment with lower average 
bodyweight gains than the controls. 
TABLE 1,.-..;.The Effect of Aureomycin Administered Orally and Parenterally Upon Growth and Feed 















Average &TOWth gains by 4 weeks in: 
Height at Chest 
Bodyweight withers circumference 
















Average feed consumed by 4 weeks (lbs.) 
















• Each group consisted of 4 Guernseys, 2 Ayrshires and I Holstein. Group A, control; B, 250 mg. aureomycin weekly by oral administration; C, 60 
mg. implant . weekly; D, 70 mg. daily by oral administration; and E, 60 mg. weekly by intramuscular injection. 
TABLE 11.-'--The Effect of Aureomycin Administered Orally and Parenterally Upon Growth and Feed 
Consumption of Dairy Calves During the First Four Weeks of Life. 
(Experiment II) 
Average growth gains by 4 weeks in: Average feed consumed by 4 weeks (lbs.) 
Height at Chest Milk Starter Hay 
Avg. initial Bodyweight · withers circumference 
Group• weight (lbs.) (lbs.) (in.) (in.) 
A 78.0 8.4 1.4 1.0 167.7 6.6 7.7 
D 76.4 16.8 1.0 1.5 173.6 13.6 8.1 
F 76.8 14.0 2.1 1.3 170.0 9.2 6.8 
G 74.4 12.8 1.6 1.3 171.4 8.7 6.8 
H 74.4 11.6 1.5 1.2 166.9 9.1 10.1 
• Each group consisted of five calves. Group A, control; D, 70 mg. aureomycin daily by oral administration; F, 500 mg. weekly by oral administration; 
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Group C had a somewhat higher incidence of scours than the con• 
trois as well as a longer average duration of each case of scours, which 
might account in part for the lower bodyweight gains observed. The 
calves in Group E had an initial bodyweight of 3.9 lbs. more than the 
controls, which perhaps should be considered when comparing the 
terminal weights of these two groups; but it is not likely that this 
factor had a material effect upon subsequent gains. 
No beneficial results were obtained from the subcutaneous im-
plantation nor the intramuscular injection of 60 mg. of aureomycin 
under the conditions of this experiment. It was not possible to deter-
mine how much time was required for the aureomycin implants or 
injections to be absorbed into the blood stream. The rate of absorption 
may have been too slow to result in sufficiently high blood concentra-
tions to be effective in stimulating growth. There is also the pos-
sibility that the level of antibiotic administered was too low to be of 
any benefit. If this last observation is correct, the low bodyweight 
gains made by Groups C and E might be caused by the added stress 
due to the mechanics of administration. 
Experiment II 
The data relative to the treatment effects in Experiment II are 
summarized in Table II. The average gain of calves receiving 70 mg. 
aureomycin daily was twice as great as that of the control calves. 
While levels of 125 or 500 mg. in single weekly oral doses re-
sulted in apparent growth responses, neither of these levels appeared 
to be as effective as 70 mg. administered daily. It appears that 500 
mg. aureomycin orally may be too large an amount in a single dose 
for an optimum growth response since the administration of a similar 
amount, 490 mg. in daily doses of 70 mg., resulted in 20 percent more 
average weight gain per calf. 
The calves in Group G receiving 250 mg. of aureomycin by weekly 
intramuscular injections gained an average of 4.4 lbs. more than the 
control animals. The gain of these calves was 76 percent as much as 
those receiving 70 mg. daily orally. It appears, therefore, that intra-
muscular injection is not as efficient as oral administration, since the 
oral administration of 250 mg. weekly in Experiment I resulted in 
weight gains equal to those in the group receiving 70 mg. daily. 
CHANGES IN WITHERS AND CHEST SIZES 
The gains in height at withers and chest circumference were small 
and inconsistent in all groups in each experiment. The calves in Ex-
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periment I which received aureomycin by oral administration had 
slightly larger gains in height at withers and chest circumference than 
the other groups. With the exception of the 70 mg. daily group with 
respect to height at withers, there tended to be similar advantages 
for the aureomycin-treated calves in Experiment II. It is doubtful 
that these small changes were materially associated with experimental 
treatment in either trial. 
FEED CONSUMPTION 
The milk consumption by all groups was rather constant. Very 
little starter or hay was consumed by the calves in any of the groups. 
However, the calves receiving 70 mg. of aureomycin daily consumed 
somewhat more starter than other calves in both experiments. 
SCOURS 
Scours was not considered a problem of serious nature due to the 
low incidence and mildness in form of most cases. Although slightly 
less scouring was observed in those groups receiving oral administra-
tions of aureomycin, it appeared that a major portion of the scouring 
was associated with errors in management and was not particularly re-
lated to experimental treatment. The latter observation was sub-
stantiated by the fact that during the course of this study there were two 
periods during which wet sawdust was inadvertently used to bed the 
calves. It was during these two periods that the most serious out-
breaks of scours occurred. 
Summary 
Two experiments were conducted to determine the effects of dif-
ferent levels of crystalline aureomycin hydrochloride administered 
orally, subcutaneously and intramuscularly upon the growth rate, feed 
consumption and general health of dairy calves during the first four 
weeks of life. 
The oral administration of 70 mg. aureomycin by capsule resulted 
in average bodyweight gains at four weeks which were 3.6 to 8.4 lbs. 
greater per calf than controls in Experiments I and II, respectively. 
In Experiment I, 250 mg. in a single weekly, oral dose was as effective 
in stimulating growth as 70 mg. administered daily. In the second 
experiment, 125 mg. and 500 mg. in single weekly, oral doses resulted 
in 3.2 and 5.6 lbs., respectively, more gain per calf than controls; but 
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this response was considerably less than the 8.4 lbs. weight advantage 
realized by the administration of 70 mg. daily in the same trial. 
The intramuscular injection and subcutaneous implantation of 
60 mg. aureomycin appeared to depress growth as compared to controls. 
When 250 mg. were injected intramuscularly, however, bodyweight 
gains were increased by 4.4 lbs. over controls as compared to an 8.4 lbs. 
increase by the daily oral administration of 70 mg. in the same trial. 
Scours was not a problem and though there was some indication 
that the oral administration of aureomycin had a controlling effect, 
it is doubtful that any relationship existed between the incidence or 
severity of scours and growth benefits in this study. 
Differences in certain body measurements and in feed consump-
tion were small and were not related consistently to the experimental 
treatments. 
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